Вы искали: rożiglitażon (Мальтийский - Английский)

avandamet rożiglitażon u metformina kloridrat
avandamet rosiglitazone and metformin hydrochloride

avandamet huwa mediċina li fiha żewġ sustanzi attivi rosiglitazone (rożiglitażon) u metformina kloridrat (metformin hydrochloride).
avandamet is a medicine that contains two active substances, rosiglitazone and metformin hydrochloride.

id-doża tal-bidu rakkommandata ta' avandamet hija ta’ 4 mg rożiglitażon u 2,000 mg metformina idrokloridrat kuljum.
the recommended starting dose of avandamet is 4 mg rosiglitazone and 2,000 mg metformin hydrochloride a day.

twettaq ukoll studju ieħor fejn ġiet ipparagunata ż-żieda ta’ rożiglitażon jew plaċebo (trattament finta) ma’ metformina.
another study was also carried out comparing the effects of adding either rosiglitazone or placebo (a dummy treatment) to metformin.

id-doża ta’ rożiglitażon tista’ tiżdied mal-metformina u tiġi aġġustata qabel ma' avandamet jingħata lill-pazjent.
the dose of rosiglitazone may be added to metformin and adjusted before a patient is switched to avandamet.

fil-każ li l-pazjent ikun qiegħed diġà juża terapija tripla, hemmhekk avandamet jingħata biex tipprovdi l-istess dożi ta’ rożiglitażon u metformina bħal qabel.
if the patient is already using triple therapy, then avandamet is given to provide the same doses of rosiglitazone and metformin as before.